-
1
-
-
12144287198
-
Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant
-
Martin A, Nolan D, Gaudieri S, et al. Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant. Proc Natl Acad Sci USA 2004;101:4180-5.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 4180-4185
-
-
Martin, A.1
Nolan, D.2
Gaudieri, S.3
-
2
-
-
33745295856
-
Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV cohort study
-
Rauch A, Nolan D, Martin A, et al. Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV cohort study. Clin Infect Dis 2006;43:99- 102.
-
(2006)
Clin Infect Dis
, vol.43
, pp. 99-102
-
-
Rauch, A.1
Nolan, D.2
Martin, A.3
-
3
-
-
33845565479
-
Screening for HLA-B*5701 reduces the frequency of abacavir hypersenitivity reactions
-
24-26 September, San Francisco, California, USA abstract 14, accessed 16 Dec
-
Reeves I, Churchill D, Fisher M. Screening for HLA-B*5701 reduces the frequency of abacavir hypersenitivity reactions. 8th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, 24-26 September 2006, San Francisco, California, USA (abstract 14). http://www.intmedpress.com/lipodystrophy/webcasts/session4cfm (accessed 16 Dec 2006).
-
(2006)
8th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV
-
-
Reeves, I.1
Churchill, D.2
Fisher, M.3
-
4
-
-
12144291194
-
Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci
-
Cao K, Moormann AM, Lyke KE, et al. Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci. Tissue Antigens 2004;63:293-325.
-
(2004)
Tissue Antigens
, vol.63
, pp. 293-325
-
-
Cao, K.1
Moormann, A.M.2
Lyke, K.E.3
-
5
-
-
12144291646
-
CNA30032 Study Team. Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some but not all populations
-
Hughes AR, Mosteller M, Bansal AT, et al. CNA30032 Study Team. Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some but not all populations. Pharmacogenomics 2004;5:203-11.
-
(2004)
Pharmacogenomics
, vol.5
, pp. 203-211
-
-
Hughes, A.R.1
Mosteller, M.2
Bansal, A.T.3
-
6
-
-
20644470742
-
Clinical and immunogenetic correlates of abacavir hypersensitivity
-
Phillips EJ, Wong GA, Kaul R, et al. Clinical and immunogenetic correlates of abacavir hypersensitivity. AIDS 2005;19:979-81.
-
(2005)
AIDS
, vol.19
, pp. 979-981
-
-
Phillips, E.J.1
Wong, G.A.2
Kaul, R.3
-
7
-
-
20144380564
-
HLA-B*5701 typing by sequence-specific amplification: Validation and comparison with sequence-based typing
-
Martin AM, Nolan D, Mallal S. HLA-B*5701 typing by sequence-specific amplification: validation and comparison with sequence-based typing. Tissue Antigens 2005;65:571-4.
-
(2005)
Tissue Antigens
, vol.65
, pp. 571-574
-
-
Martin, A.M.1
Nolan, D.2
Mallal, S.3
-
8
-
-
3042634326
-
Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity
-
Hughes DA, Vilar FJ, Ward CC, et al. Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity. Pharmacogenetics 2004;14:335-42.
-
(2004)
Pharmacogenetics
, vol.14
, pp. 335-342
-
-
Hughes, D.A.1
Vilar, F.J.2
Ward, C.C.3
-
9
-
-
30944449815
-
Personalised medicines: Hopes and realities
-
The Royal Society, Report September
-
The Royal Society. Personalised medicines: hopes and realities. Report September 2005.
-
(2005)
-
-
|